Notice2022-09786
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 6, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Traveler-based SARS-CoV-2 Genomic Surveillance. The information collection will monitor for the importation of SARS-CoV-2 variants among arriving international air travelers at select U.S. airports.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 88 (Friday, May 6, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 88 (Friday, May 6, 2022)]
[Notices]
[Pages 27155-27156]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-09786]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-22ET; Docket No. CDC-2022-0060]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Traveler-based SARS-CoV-2 Genomic Surveillance. The information
collection will monitor for the importation of SARS-CoV-2 variants
among arriving international air travelers at select U.S. airports.
DATES: CDC must receive written comments on or before July 5, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0060 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and
[[Page 27156]]
Prevention, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30329;
Telephone: 404-639-7570; Email: <a href="/cdn-cgi/l/email-protection#b6d9dbd4f6d5d2d598d1d9c0"><span class="__cf_email__" data-cfemail="4a2527280a292e29642d253c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Traveler-based SARS-CoV-2 Genomic Surveillance--New--National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
The traveler-based SARS-CoV-2 genomic surveillance project was
developed as a surveillance platform for early detection of imported
and emerging SARS-CoV-2 variants among international air travelers
arriving into the United States. Despite layered mitigation measures,
international travel facilitates spread of SARS-CoV-2, including novel
variants of concern (VOCs). Although SARS-CoV-2 genomic sequencing has
increased significantly during the pandemic, there is still a gap in
early detection of emerging variants among arriving travelers.
To address this gap, in September 2021, the Travelers' Health
Branch, in collaboration with private partners, implemented a voluntary
SARS-CoV-2 genomic surveillance program with the goal of early
detection of novel VOCs. Surveillance for new and emerging variant
strains among travelers can provide researchers and public health
officials critical time to collect information about the
transmissibility, virulence, and effectiveness of existing vaccines,
diagnostics, and therapeutics. The project is conducted with external
partners and groups within DGMQ and across CDC, including the Office of
Advanced Molecular Detection. The program began at New York's John F.
Kennedy International Airport in September 2021 and later expanded to
include Newark Liberty International, San Francisco International, and
Hartsfield-Jackson Atlanta International airports. Information
collection for this project is currently approved under a Public Health
Emergency PRA Waiver.
Project data is collected as follows: A volunteer sample of
travelers, 18 years and older, from selected flights from South Asia,
South America, Europe, and southern Africa, complete an informed
consent form and fill-out a questionnaire on enrollment at the airport.
The questionnaire includes demographic, travel, and clinical
information. The voluntary surveillance project also includes
laboratory data collection as follows: Airport collection of nasal
samples from arriving travelers and follow-up collection of individual
at-home saliva samples 3-5 days later. Travelers participating in
individual, at home sample collection also complete an electronic
health information questionnaire prior to submission of their samples
and have the opportunity to fill out an evaluation survey.
CDC requests OMB approval for an estimated 169,433 annual burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Participant with sample Participant 88,400 1 1 88,400
collected in-airport. information
intake form
(for pooled
testing).
Participant with sample Participant 44,200 1 1.5 66,300
collected at home. intake form
(for individual
at-home
testing).
Participant with sample Evaluation 44,200 1 20/60 14,733
collection at-home. Survey Form.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 169,433
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-09786 Filed 5-5-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 6, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.